Novartis Entresto® granted expanded indication in chronic heart failure by FDA
- Entresto is the first and only therapy approved in the US to treat patients diagnosed with guideline-defined heart fai
AUSTIN, Texas and ENSCHEDE, The Netherlands, Feb. 16, 2021 (GLOBE NEWSWIRE) — Lithium Werks BV is proud to annou…
Continue ReadingQUEBEC CITY and SEOUL, Korea, Feb. 16, 2021 (GLOBE NEWSWIRE) — LeddarTech®, an industry leader in environmenta…
Continue Readingควิเบก ซิตี้และโซล, เกาหลี, Feb. 16, 2021 (GLOBE NEWSWIRE) — LeddarTech® ผู้นำอุตสาหกรรมด้านโซลูชั
Sixty-six million years ago, a huge celestial object struck off the coast of what is now Mexico, triggering a catastrop…
Continue Reading